- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05351853
Metabolic Effects of Plant-based Diet
October 12, 2022 updated by: Koç University
Metabolic Effects of Plant-based Diet on Healthy Young Adults
The purpose of this study is to assess the metabolic effects of plant based diet on healthy young adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
An internet announcement will be made and 60 participants who meet the eligibility requirements will be randomly selected.
After being informed about study, all participants (60 omnivores) giving written informed consent will be assigned to the vegan and vegetarian groups of the study according to their preferences, while 20 participants will continue to be omnivores as the control group.
At week 0 and 24, blood samples, urine samples, proton density fat fraction MRI evaluations and body composition analyze will be completed.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34010
- Koç University Medical Faculty
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being 18-40 years old,
- BMI is 18-30 kg/m2,
- Having no chronic diseases,
- Not smoking
Exclusion Criteria:
- Having chronic disease,
- Being older than 40 years old or younger than 18 years old,
- Smoking,
- Alcoholism or drinking more than 140 gr/week of alcohol,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Control Group
20 healthy individual will be in the control group.
Participants of control group will not change their diet and will continue omnivore diet.
|
This study will evaluate effects of plant based diets (vegan and vegetarian).
60 omnivore individuals will be included.
20 of the participants will continue their omnivore diet as control group.
20 of the participants will change their diet to vegetarian, and 20 of them will change their diet to vegan.
Other Names:
|
Other: Vegetarian
20 healthy individual will be in the control group.
Participants of this group will change their diet from omnivore to vegetarian (no meat /meat products) after the beginning of the study.
|
20 of the participants will change their diet to vegetarian diet.
In this group participants will not eat any meat or meat product but can eat/drink milk products, egg and other animal products.
|
Other: Vegan
20 healthy individual will be in the control group.
Participants of this group will change their diet from omnivore to vegan (%100 plant based) after the beginning of the study.
|
20 of the participants will change their diet to vegan diet.
In this group participants will not eat any kind of animal products.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Liver Steatosis at 6 months
Time Frame: At week 24 liver steatosis change will be compared between the groups.
|
Liver steatosis change will be compared between groups at the end of the study.
|
At week 24 liver steatosis change will be compared between the groups.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Insulin Resistance at 6 months
Time Frame: At week 24 insulin resistance change will be compared between the groups.
|
Insulin resistance change will be compared between groups at the end of the study.
|
At week 24 insulin resistance change will be compared between the groups.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2021
Primary Completion (Actual)
July 30, 2022
Study Completion (Actual)
July 30, 2022
Study Registration Dates
First Submitted
December 8, 2021
First Submitted That Met QC Criteria
April 22, 2022
First Posted (Actual)
April 28, 2022
Study Record Updates
Last Update Posted (Actual)
October 14, 2022
Last Update Submitted That Met QC Criteria
October 12, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 28041993
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatty Liver
-
Shiraz University of Medical SciencesCompletedFatty Liver | Fatty Liver, NonalcoholicIran, Islamic Republic of
-
Hoffmann-La RocheCompletedFatty Liver, Non-alcoholic Fatty Liver Disease, NAFLDGermany, Austria
-
GenfitTerminatedNon-Alcoholic Fatty LiverNetherlands
-
Medical College of WisconsinENDRA Life Sciences, Inc.RecruitingFatty Liver | NAFLD | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non-alcoholic Fatty Liver | NASH | Fatty Liver DiseaseUnited States
-
Cairo UniversityRecruitingNon-Alcoholic Fatty Liver DiseaseEgypt
-
Miriam Vos, MDImmuron Ltd.; Advanced MR Analytics ABCompletedNonalcoholic Fatty Liver Disease (NAFLD)United States
-
Nehal Abou SeadaCompletedNon-Alcoholic Fatty Liver Disease
-
HaEmek Medical Center, IsraelTerminatedPatients With Fatty Liver DiseaseIsrael
-
AB Biotics, SACompletedNon Alcoholic Fatty LiverMexico
-
University of L'AquilaRecruitingNAFLD- Non Alcoholic Fatty Liver DiseaseItaly
Clinical Trials on Omnivore
-
Stanford UniversityCompletedInflammation | Glucose Intolerance | Microbiome | Lipid Metabolism | Weight Change, Body | Immune FunctionUnited States
-
University of BariUniversity of Bologna; Federico II University; University Of Perugia; University... and other collaboratorsUnknownDiet and Human MicrobiotaItaly